BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26864375)

  • 1. Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
    Pinto N; Mayfield JR; Raca G; Applebaum MA; Chlenski A; Sukhanova M; Bagatell R; Irwin MS; Little A; Rawwas J; Gosiengfiao Y; Delattre O; Janoueix-Lerosey I; Lapouble E; Schleiermacher G; Cohn SL
    Pediatr Blood Cancer; 2016 Jun; 63(6):1019-23. PubMed ID: 26864375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable
    Ambros IM; Tonini GP; Pötschger U; Gross N; Mosseri V; Beiske K; Berbegall AP; Bénard J; Bown N; Caron H; Combaret V; Couturier J; Defferrari R; Delattre O; Jeison M; Kogner P; Lunec J; Marques B; Martinsson T; Mazzocco K; Noguera R; Schleiermacher G; Valent A; Van Roy N; Villamon E; Janousek D; Pribill I; Glogova E; Attiyeh EF; Hogarty MD; Monclair TF; Holmes K; Valteau-Couanet D; Castel V; Tweddle DA; Park JR; Cohn S; Ladenstein R; Beck-Popovic M; De Bernardi B; Michon J; Pearson ADJ; Ambros PF
    J Clin Oncol; 2020 Nov; 38(31):3685-3697. PubMed ID: 32903140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population.
    Lim H; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
    J Korean Med Sci; 2020 Apr; 35(14):e82. PubMed ID: 32281311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
    Parodi S; Pistorio A; Erminio G; Ognibene M; Morini M; Garaventa A; Gigliotti AR; Haupt R; Frassoni F; Pezzolo A
    Pediatr Blood Cancer; 2019 May; 66(5):e27635. PubMed ID: 30688024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.
    Defferrari R; Mazzocco K; Ambros IM; Ambros PF; Bedwell C; Beiske K; Bénard J; Berbegall AP; Bown N; Combaret V; Couturier J; Erminio G; Gambini C; Garaventa A; Gross N; Haupt R; Kohler J; Jeison M; Lunec J; Marques B; Martinsson T; Noguera R; Parodi S; Schleiermacher G; Tweddle DA; Valent A; Van Roy N; Vicha A; Villamon E; Tonini GP
    Br J Cancer; 2015 Jan; 112(2):290-5. PubMed ID: 25356804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without
    Wieczorek A; Szewczyk K; Klekawka T; Stefanowicz J; Ussowicz M; Drabik G; Pawinska-Wasikowska K; Balwierz W
    Front Oncol; 2023; 13():1134772. PubMed ID: 36865795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
    Morales La Madrid A; Nall MB; Ouyang K; Minor A; Raca G; Kent P; Miller I; Schleiermacher G; Janoueix-Lerosey I; Cohn SL
    Pediatr Blood Cancer; 2013 Feb; 60(2):332-5. PubMed ID: 22997192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue.
    Zielenska M; Marrano P; Thorner P; Pei J; Beheshti B; Ho M; Bayani J; Liu Y; Sun BC; Squire JA; Hao XS
    Cytogenet Genome Res; 2004; 107(1-2):77-82. PubMed ID: 15305059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.
    Bogen D; Brunner C; Walder D; Ziegler A; Abbasi R; Ladenstein RL; Noguera R; Martinsson T; Amann G; Schilling FH; Ussowicz M; Benesch M; Ambros PF; Ambros IM
    Int J Cancer; 2016 Jul; 139(1):153-63. PubMed ID: 26910568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.
    Chicard M; Boyault S; Colmet Daage L; Richer W; Gentien D; Pierron G; Lapouble E; Bellini A; Clement N; Iacono I; Bréjon S; Carrere M; Reyes C; Hocking T; Bernard V; Peuchmaur M; Corradini N; Faure-Conter C; Coze C; Plantaz D; Defachelles AS; Thebaud E; Gambart M; Millot F; Valteau-Couanet D; Michon J; Puisieux A; Delattre O; Combaret V; Schleiermacher G
    Clin Cancer Res; 2016 Nov; 22(22):5564-5573. PubMed ID: 27440268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.
    Cetinkaya C; Martinsson T; Sandgren J; Träger C; Kogner P; Dumanski J; Díaz de Ståhl T; Hedborg F
    BMC Cancer; 2013 May; 13():231. PubMed ID: 23656755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of archival formalin-fixed paraffin-embedded mouse liver samples for use with the Agilent gene expression microarray platform.
    Jackson AF; Williams A; Moffat I; Phillips SL; Recio L; Waters MD; Lambert IB; Yauk CL
    J Pharmacol Toxicol Methods; 2013; 68(2):260-268. PubMed ID: 23458726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma.
    Lennon PA; Zhuang Y; Pierson D; Zhang X; Williams C; Perez C; Lin P
    Cancer; 2009 Jan; 115(2):345-54. PubMed ID: 19109814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays.
    Mirza MK; Sukhanova M; Stölzel F; Onel K; Larson RA; Stock W; Ehninger G; Kuithan F; Zöphel K; Reddy P; Joseph L; Raca G
    Leuk Res; 2014 Sep; 38(9):1091-6. PubMed ID: 25088808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.
    Pezzolo A; Rossi E; Gimelli S; Parodi F; Negri F; Conte M; Pistorio A; Sementa A; Pistoia V; Zuffardi O; Gambini C
    Neuro Oncol; 2009 Apr; 11(2):192-200. PubMed ID: 18923191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of segmental alterations determines progression in neuroblastoma.
    Schleiermacher G; Janoueix-Lerosey I; Ribeiro A; Klijanienko J; Couturier J; Pierron G; Mosseri V; Valent A; Auger N; Plantaz D; Rubie H; Valteau-Couanet D; Bourdeaut F; Combaret V; Bergeron C; Michon J; Delattre O
    J Clin Oncol; 2010 Jul; 28(19):3122-30. PubMed ID: 20516441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.
    Panzeri E; Conconi D; Antolini L; Redaelli S; Valsecchi MG; Bovo G; Pallotti F; Viganò P; Strada G; Dalprà L; Bentivegna A
    PLoS One; 2011; 6(9):e24237. PubMed ID: 21909424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).
    Schleiermacher G; Michon J; Ribeiro A; Pierron G; Mosseri V; Rubie H; Munzer C; Bénard J; Auger N; Combaret V; Janoueix-Lerosey I; Pearson A; Tweddle DA; Bown N; Gerrard M; Wheeler K; Noguera R; Villamon E; Cañete A; Castel V; Marques B; de Lacerda A; Tonini GP; Mazzocco K; Defferrari R; de Bernardi B; di Cataldo A; van Roy N; Brichard B; Ladenstein R; Ambros I; Ambros P; Beiske K; Delattre O; Couturier J
    Br J Cancer; 2011 Dec; 105(12):1940-8. PubMed ID: 22146831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
    Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
    Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R; Hero B; Simon T; Berthold F
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.